AlphaFold predicted structure
ALDH1A3 · P47895

Mean pLDDT
95.6/ 100
Very high
512 residues
Confidence breakdown
- Very high(≥ 90)93%
- Confident(70–90)3%
- Low(50–70)1%
- Very low(< 50)3%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
aldehyde dehydrogenase 1 family member A3
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Anophthalmia or microphthalmia
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalOcular coloboma
BIALLELIC, autosomal or pseudoautosomalStructural eye disease
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalIsolated anophthalmia - microphthalmia
microphthalmia
anophthalmia-microphthalmia syndrome
isolated anophthalmia-microphthalmia syndrome
nanophthalmia
microphthalmia, isolated, with coloboma
amyotrophic lateral sclerosis
nutritional deficiency disease
autism
Hypoventilation
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Retinaldehyde dehydrogenase 3
Catalyzes the NAD-dependent oxidation of aldehyde substrates, such as all-trans-retinal and all-trans-13,14-dihydroretinal, to their corresponding carboxylic acids, all-trans-retinoate and all-trans-13,14-dihydroretinoate, respectively (By similarity) (PubMed:27759097). High specificity for all-trans-retinal as substrate, can also accept acetaldehyde as substrate in vitro but with lower affinity (PubMed:27759097). Required for the biosynthesis of normal levels of retinoate in the embryonic ocular and nasal regions; a critical lipid in the embryonic development of the eye and the nasal region (By similarity)
ALDH1A3 · P47895

Mean pLDDT
95.6/ 100
Very high
512 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0